Testing effectiveness (Phase 2)Ended earlyNCT00089076
What this trial is testing
MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 18